CDMOs in a High-Demand, Low-Capacity Sterile Outsourcing Landscape
The sterile outsourcing sector is facing increasing pressure due to increasing demand for biology with small batches and limited production capacity. CDMOs must be suitable through facility redesign, specialized expertise, and close operation to meet the developed needs of biotechnology companies and ensure timely access to clinical and commercial production.
https://www.pharmafocusamerica.....com/strategy/cdmos-